These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 3429592)

  • 21. A simple spectrophotometric determination of solid supported amino groups.
    Ngo TT
    J Biochem Biophys Methods; 1986 Jun; 12(5-6):349-54. PubMed ID: 3734326
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sensitive trace-first liquid chromatographic determination of 4-aminopyridine in 3,4-diaminopyridine.
    Perry JA; Chang M
    J Pharm Sci; 1990 May; 79(5):437-9. PubMed ID: 2352165
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of urine metabolites of TFAP, a cyclooxygenase-1 inhibitor.
    Kakuta H; Fukai R; Xiaoxia Z; Ohsawa F; Bamba T; Hirata K; Tai A
    Bioorg Med Chem Lett; 2010 Mar; 20(6):1840-3. PubMed ID: 20185310
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics of 4-aminopyridine in cattle.
    Kitzman JV; Wilson RC; Booth NH; Zahner JM; Hendricks HL; Bush PB
    Am J Vet Res; 1984 Dec; 45(12):2625-7. PubMed ID: 6524755
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitation of flupirtine and its active acetylated metabolite by reversed-phase high-performance liquid chromatography using fluorometric detection.
    Narang PK; Tourville JF; Chatterji DC; Gallelli JF
    J Chromatogr; 1984 Jan; 305(1):135-43. PubMed ID: 6707137
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ultrasound driven synthesis of reversed-phase stationary phases for liquid chromatography using 4-dimethyl-aminopyridine as acid-acceptor.
    Sentell KB; Barnes KW; Dorsey JG
    J Chromatogr; 1988 Nov; 455():95-104. PubMed ID: 3235626
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Residues of 4-aminopyridine in poisoned birds.
    Frank R; Sirons GJ; Wilson D
    Bull Environ Contam Toxicol; 1981 Mar; 26(3):389-92. PubMed ID: 7284636
    [No Abstract]   [Full Text] [Related]  

  • 28. 4-aminopyridine; analysis of the substance and a method for the preparation of a solution for injection in man.
    Uges DR; Huizinga T
    Pharm Acta Helv; 1981; 56(6):158-62. PubMed ID: 7255503
    [No Abstract]   [Full Text] [Related]  

  • 29. 4-Aminopyridine kinetics.
    Uges DR; Sohn YJ; Greijdanus B; Scaf AH; Agoston S
    Clin Pharmacol Ther; 1982 May; 31(5):587-93. PubMed ID: 7075108
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and evaluation of a series of 2,4-diaminopyridine derivatives as potential positron emission tomography tracers for neuropeptide Y Y1 receptors.
    Kameda M; Ando M; Nakama C; Kobayashi K; Kawamoto H; Ito S; Suzuki T; Tani T; Ozaki S; Tokita S; Sato N
    Bioorg Med Chem Lett; 2009 Sep; 19(17):5124-7. PubMed ID: 19640706
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anharmonic vibrational analysis of 3,4-diaminopyridine and 3-aminopyridine by density functional theory calculations.
    Karpagam J; Sundaraganesan N; Kalaichelvan S; Sebastian S
    Spectrochim Acta A Mol Biomol Spectrosc; 2010 Sep; 76(5):502-12. PubMed ID: 20483656
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of some pharmacological properties of 4-aminopyridine and 3,4-diaminopyridine in vivo.
    Houston T; Pleuvry BJ
    Br J Anaesth; 1984 Oct; 56(10):1139-42. PubMed ID: 6148094
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Site of action and active form of aminopyridines in squid axon membranes.
    Kirsch GE; Narahashi T
    J Pharmacol Exp Ther; 1983 Jul; 226(1):174-9. PubMed ID: 6306223
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [3,4-Diaminopyridine and 4-aminopyridine evoked neurotransmitter release].
    Huang HY; Dai SP
    Zhongguo Yao Li Xue Bao; 1991 Jan; 12(1):28-32. PubMed ID: 1950580
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of 3,4-diaminopyridine-induced coronary oscillation by adenyl compounds.
    Yoshinaka Y; Uchida Y
    Eur J Pharmacol; 1986 Aug; 127(3):173-8. PubMed ID: 3758179
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interaction of 2,4-diaminopyridine with cholinesterase inhibitors.
    Biessels PT; Houwertjes MC; Agoston S; Horn AS
    Arch Int Pharmacodyn Ther; 1988; 293():228-35. PubMed ID: 3421780
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neurotoxicity of quinolinate in the rat nucleus basalis magnocellularis.
    Boegman RJ; Metcalf R; Riopelle RJ; Ludwin SK
    Brain Res; 1987 Aug; 417(2):315-20. PubMed ID: 2958107
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Determination of A 3,4-diaminopyridine in plasma by liquid chromatography with electrochemical detection using solid-phase extraction.
    Goulay-Dufaÿ S; Do B; Le Hoang MD; Raust JA; Graffard H; Guyon F; Pradeau D
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Jun; 805(2):261-6. PubMed ID: 15135099
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The use of aminopyridines in neurological disorders.
    Sedehizadeh S; Keogh M; Maddison P
    Clin Neuropharmacol; 2012; 35(4):191-200. PubMed ID: 22805230
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potentiation between neostigmine and 3,4-diaminopyridine in antagonizing the neuromuscular block induced by D-tubocurarine.
    Chang CC; Su MJ; Shieh BH; Lin HL; Hong SJ
    Proc Natl Sci Counc Repub China B; 1984 Jul; 8(3):235-9. PubMed ID: 6100937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.